TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing October 10, 1980
TCL Archive NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done January 20, 1984
